Discover 1,729 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Location: Durham NC, Charleston SC, Birmingham AL, New York NY
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06588556
Recruiting
Safety of RSV Preventive Monoclonal Antibody
for
Fever, Adverse Event Following Immunisation
Location: Durham NC, Atlanta GA, Cincinnati OH, New York NY,
Sponsor: Duke University
Sex: All
Age: 0
Code: NCT07158814
Recruiting
Intent of Surgery for IPMN
for
Intraductal Papillary Mucinous Neoplasm
Location: Durham NC, Baltimore MD, New York NY, Boston MA,
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT07216521
Recruiting
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
for
Progressive Metastatic Castrate Resistant Prostate Cancer
Location: Durham NC, Atlanta GA, Denver CO, Jacksonville FL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07206056
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Durham NC, Pinehurst NC, Greenville SC, Richmond VA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Durham NC, Glen Burnie MD, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Durham NC, Cincinnati OH, Cleveland OH, New York NY,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06859762
Phase1, Recruiting
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
for
Adamantinomatous Craniopharyngioma,
Location: Durham NC, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05233397
Phase2, Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
for
Recurrent Glioblastoma IDH Wildtype
Location: Durham NC
Sponsor: Darell Bigner
Sex: All
Age: 18+
Code: NCT06455605
Phase1, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Durham NC, Washington D.C. DC, Atlanta GA, Baltimore MD,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase1, Phase2, Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Durham NC, Charlotte NC, Washington D.C. DC, Atlanta GA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Durham NC, Charlotte NC, Roanoke VA, Greenville SC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Ultrasound for Evaluation of Percutaneous G-tube Position
for
Gastrostomy
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 0 - 18
Code: NCT06361498
Recruiting
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Durham NC, Washington D.C. DC, Baltimore MD,